Anti-CD168 antibody [EPR4054]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(2 Reviews)
|
(22 Publications)
Rabbit Recombinant Monoclonal CD168 antibody. Suitable for IP, WB, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 22 publications.
View Alternative Names
CD168, IHABP, RHAMM, HMMR, Hyaluronan mediated motility receptor, Intracellular hyaluronic acid-binding protein, Receptor for hyaluronan-mediated motility
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4054] (AB124729)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human gastric carcinoma tissue sections labeling CD168 with purified ab124729 at 1 : 250 dilution (7.7 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer pH9.0. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD168 antibody [EPR4054] (AB124729)
Immunohistochemical analysis of paraffin-embedded human testis tissue using unpurified ab124729 at 1/50 - 1/100 dilution
- IP
Lab
Immunoprecipitation - Anti-CD168 antibody [EPR4054] (AB124729)
ab124729 (purified) at 1 : 100 dilution (2ug) immunoprecipitating CD168 in MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysate.
Lane 1 (input) : MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysate 10ug
Lane 2 (+) : ab124729 & MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab124729 in MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-CD168 antibody [EPR4054] (ab124729)
Predicted band size: 84 kDa
Observed band size: 85 kDa
false
- WB
Lab
Western blot - Anti-CD168 antibody [EPR4054] (AB124729)
5% NFDM/TBST
All lanes:
Western blot - Anti-CD168 antibody [EPR4054] (ab124729) at 1/1000 dilution
Lane 1:
MDA-MB-435 (Human mammary gland ductal carcinoma melanocyte) whole cell lysates at 20 µg
Lane 2:
RAW264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysates at 15 µg
Lane 3:
PC-12 (Rat adrenal gland pheochromocytoma ) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 125 kDa,84 kDa
false
- WB
Lab
Western blot - Anti-CD168 antibody [EPR4054] (AB124729)
Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : Empty
Lane 3 : CD168 knockout HAP1 whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab124729 observed at 90 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab124729 was shown to specifically react with CD168 when CD168 knockout samples were used. Wild-type and CD168 knockout samples were subjected to SDS-PAGE. ab124729 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at a 1/1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD168 antibody [EPR4054] (ab124729)
Predicted band size: 84 kDa
false
- WB
Unknown
Western blot - Anti-CD168 antibody [EPR4054] (AB124729)
All lanes:
Western blot - Anti-CD168 antibody [EPR4054] (ab124729)
Lane 1:
MDA-MB-435 cell lysate at 10 µg
Lane 2:
LnCaP cell lysate at 10 µg
Lane 3:
T47-D cell lysate at 10 µg
Predicted band size: 84 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-CD168 antibody [EPR4054] (AB124729)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (3)
-
Anti-CD168 antibody [EPR4054] - Low endotoxin, Azide free
-
Anti-CD168 antibody [EPR4054] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD168 antibody [EPR4054]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Hyaluronan-mediated motility receptor plays an important role in the regulation of the extracellular matrix (ECM) by binding to hyaluronan a significant component of the ECM. CD168 has a vital function in cell surface signaling processes facilitating communication between cells and their environment. The protein operates in a complex with elements like growth factor receptors enhancing its ability to modulate cellular responses. This interaction allows CD168 to significantly influence processes like wound healing and tissue remodeling.
Pathways
Hyaluronan-mediated motility receptor participates in the Rho signaling pathway important for cytoskeletal organization and cell movement. Through this pathway CD168 interacts directly with proteins such as GTPases including members of the Rho family like RhoA which play key roles in the reorganization of the actin cytoskeleton. CD168 also relates to the PI3K/AKT pathway influencing cellular survival and proliferation by interacting with proteins such as PI3K integrally involved in cellular growth and response to extracellular signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 29:337-347 PubMed40051130
2025
Applications
Unspecified application
Species
Unspecified reactive species
Protein & cell 16:28-48 PubMed38721690
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 6:1226 PubMed38049528
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer communications (London, England) 43:981-1002 PubMed37405956
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:106862 PubMed37275516
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer genomics & proteomics 20:203-210 PubMed36870687
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 23:125 PubMed36750807
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell chemical biology 30:188-202.e6 PubMed36720221
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:1895 PubMed35393420
2022
Applications
Unspecified application
Species
Unspecified reactive species
PeerJ 9:e12624 PubMed35036134
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com